Publications - IR Sant Pau

Search

01/03/2025 Bimekizumab demonstrates effective responses and safety in hidradenitis suppurativa: Short-term real-world observational multicentric study from Spain

Mansilla-Polo, M, Benvant, MP, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-García, R, Matellanes-Palacios, M, Martín-Ezquerra, G, Alfageme, F, Blanco, CC, López-Villaescusa, MT, Salmons, PG, Martorell, A, Muñoz, BE, Navarro-Blanco, F, Torregrosa, DM, Barrales, CC, Leyva, AM, Botella-Estrada, R. Bimekizumab demonstrates effective responses and safety in hidradenitis suppurativa: Short-term real-world observational multicentric study from Spain. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).

01/03/2025 Advanced Doppler Ultrasound Insights: A Multicenter Prospective Study on Healthy Skin

Giavedoni, P, Romaní, J, de Cabo, F, García-Martínez, FJ, Quintana-Codina, M, Roè-Crespo, E, de Vega, IF, Soria-Gili, X, Aguayo-Ortiz, R, Garbayo-Salmons, P, Castillo, G, Vidal-Sarró, D, Mollet, J, Serra, L, Gonzalez, C, López-Trujillo, E, Just, M, Combalia, M, Podlipnik, S, Malvehy, J, Wortsman, X. Advanced Doppler Ultrasound Insights: A Multicenter Prospective Study on Healthy Skin. Diagnostics. 2025; 15(5)DOI:10.3390/diagnostics15050569. PMID:40075816. IF:3.300(Q1/2D).

01/03/2025 Lymphatic Patterns in the Superficial Circumflex Iliac Artery Perforator Flap

Campos, J, Suominen, S, Pons, G, Al-Sakkaf, AM, Lusetti, I, Sirota, M, Vela, F, Pires, L, Sánchez-Margallo, F, Abellán, E, Masiá, J. Lymphatic Patterns in the Superficial Circumflex Iliac Artery Perforator Flap. JOURNAL OF RECONSTRUCTIVE MICROSURGERY. 2025; 41(03)DOI:10.1055/a-2340-9629. PMID:38848754. IF:2.300(Q2/3D).

01/03/2025 Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation

Albisinni, S, Orecchia, L, Mjaess, G, Aoun, F, Del Giudice, F, Antonelli, L, Moschini, M, Soria, F, Mertens, LS, Gallioli, A, Marcq, G, Pradere, B, Bochner, B, Breda, A, Briganti, A, Catto, J, Decaestecker, K, Gontero, P, Kamat, A, Lambert, E, Minervini, A, Mottrie, A, Roupret, M, Shariat, S, Wijburg, C, Rieken, M, Wiklund, P, Mari, A. Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation. EJSO. 2025; 51(3)DOI:10.1016/j.ejso.2024.109543. PMID:39799856. IF:2.900(Q1/2D).

01/03/2025 Patient-side performance metrics in robotic surgery: international Delphi-based consensus from the Junior European Association of Urology Robotic Section/Young Academic Urologists

Würnschimmel, C, Paciotti, M, Wenzel, M, Bravi, CA, De Groote, R, Dell'Oglio, P, Di Maida, F, Moschovas, MC, Piramide, F, Turri, F, Andras, I, Sorce, G, Liakos, N, Gallagher, A, Veneziano, D, Brouwers, T, Liatsikos, E, Breda, A, Larcher, A. Patient-side performance metrics in robotic surgery: international Delphi-based consensus from the Junior European Association of Urology Robotic Section/Young Academic Urologists. BJU INTERNATIONAL. 2025; 135(3)DOI:10.1111/bju.16638. PMID:39807761. IF:4.400(Q1/2D).

01/03/2025 Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group

Marcq, G, Kassouf, W, Roumiguié, M, Pradere, B, Mertens, LS, Albisinni, S, Cimadamore, A, Teoh, JYC, Moschini, M, Laukhtina, E, Mari, A, Soria, F, Gallioli, A, del Giudice, F, d'Andrea, D, Krajewski, W, Beauval, JB, Xylinas, E, Pouessel, D, Sargos, P, Ploussard, G. Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group. Actas Urologicas Espanolas. 2025; 49(2)DOI:10.1016/j.acuro.2025.501701. PMID:39938643. IF:1.200(Q3/7D).

01/03/2025 The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis

Moretto, S, Piccolini, A, Gallioli, A, Contieri, R, Buffi, N, Lughezzani, G, Breda, A, Baboudjian, M, van Rhijn, BW, Roupret, M, Uleri, A, Pradere, B. The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2025; 43(3)DOI:10.1016/j.urolonc.2024.10.035. PMID:39592361. IF:2.300(Q2/5D).

01/03/2025 Is New Always Better? Comparing the Piranha© and Multicut© Morcellators During Endoscopic Enucleation of the Prostate: A Prospective Randomized Trial

Schwartzmann, I, Hernandez-Peñalver, P, Alejo, AF, Gonzalez, PI, Grillo, LM, Montlleó, M, Castro, EM, Diana, P, Breda, A, Palou, J, Roca, JPD. Is New Always Better? Comparing the Piranha© and Multicut© Morcellators During Endoscopic Enucleation of the Prostate: A Prospective Randomized Trial. JOURNAL OF ENDOUROLOGY. 2025; 39(3)DOI:10.1089/end.2024.0581. PMID:39932730. IF:2.800(Q2/3D).

01/03/2025 Complications of catheterizable conduits in patients with bladder exstrophy: A long-term study

Iriarte, JCO, Quiroz, Y, Boix, AB, Jimenez, R, Bujons, A. Complications of catheterizable conduits in patients with bladder exstrophy: A long-term study. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Robot-assisted versus open kidney transplantation in patients who previously underwent an open kidney transplant: A propensity score matching analysis

Afferi, L, Gallioli, A, Etcheverry, B, Vangeneugden, J, Mercier, J, Cannoletta, D, Territo, A, Prudhomme, T, Masieri, L, Pecoraro, A, Benitez, NO, Donnini,, Garcia-Baquero, R, Ortved, M, Rohrsted, M, Roder, A, Dagnaes-Hansen, JA, Vigues, F, Doumerc, N, Campi, R, Serni, S, Decaestecker, K, Bred, A. Robot-assisted versus open kidney transplantation in patients who previously underwent an open kidney transplant: A propensity score matching analysis. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Impact of injection density following water vapor thermal therapy for benign prostatic obstruction

Alejo, AF, Povo, I, Secco, S, Garcia, S, Fernández, E, D'Anna, M, Parejo, V, Torneo, I, Ferrari, G, Varvello, F, de León, JP, Palou, J, Cindolo, L, Schwartzmann, I. Impact of injection density following water vapor thermal therapy for benign prostatic obstruction. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Robot-assisted versus open kidney transplantation from living donor

Afferi, L, Ortved, M, Dagnaes-Hansen, JA, Masieri, L, Pecoraro, A, Etcheverry, B, Gallioli, A, Cannoletta, D, Territo, A, Vangeneugden, J, Desender, L, Mercier, J, Prudhomme, T, Benitez, NO, Fontana, G, Garcia-Baquero, R, Rohrsted, M, Roder, A, Vigues, F, Doumerc, N, Campi, R, Serni, S, Decaestecker, K, Breda, A. Robot-assisted versus open kidney transplantation from living donor. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Active surveillance of grade group 2 prostate cancer: Oncological outcomes from a contemporary European cohort

Uleri, A, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, An-Nader, M, Dariane, C, Baud, H, Olivier, J, Sanguedolce, F, Rios, AR, Bernard,, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G, Baboudjian, M. Active surveillance of grade group 2 prostate cancer: Oncological outcomes from a contemporary European cohort. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Robot-assisted kidney transplantation (RAKT) using right vs. left kidney: Implications for living donors nefrectomy

Pecoraro, A, Catucci, CL, Territo, A, Gallioli, A, Etcheverry, B, Musquera, M, Prudhomme, T, Zeushner, P, Volpe, A, Baquero, RG, Kocak, B, Mirza, I, Stockle, M, Rohrsted, M, Canda, E, Roder, A, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Masieri, L, Serni, S, Breda, A, Campi, R. Robot-assisted kidney transplantation (RAKT) using right vs. left kidney: Implications for living donors nefrectomy. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties

Martin, IJP, Guzmán, EF, Polo, MM, Martin, MA, Pascual, EF, Samaniego, MP, Pascual, EM, González, AR, González, BM, Sanz, IP, Jimenez, CP, Bonilla, AS, Morcillo, JCR, Fes, E, Suárez, JMG, Ortega, JL, Roca, JPD, Juanatey, FC. Prospective multicenter long-term analysis of oral morbidity after oral mucosa grafts harvesting for substitution or augmentation urethroplasties. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series

Territo, A, Afferi, L, Musquera, M, Sopena, HMG, Pecoraro, A, Campi, R, Gallioli, A, Etcheverry, B, Prudhomme, T, Vangeneugden, J, Ortved, M, Roder, A, Zeuschner, P, Volpe, A, Garcia-Baquero, R, Kocak, B, Mirza,, Fornara, P, Doumerc, N, Decaestecker, K, Serni, S, Vigues, F, Alcaraz, A, Breda, A. Robot-assisted kidney transplantation (RAKT): Surgical and functional outcomes from a large series. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU)

De Oliveira, TMR, Somani, B, Browers, T, Veneziano, D, Redorta, JP, Biyani, CS, Kallidonis, P, Kasivisvanathan,, Zondervan, P, Petrut, B, Verze, P, Phe, VR, Raison, N, Silay, MS, Larche, A, Boissier, R, Liatsikos, E. SISE matters: A novel approach to hands-on training by the European Association of Urology (EAU). EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress

Guerrero-Ramos, F, Chang, S, Dickstein, RJ, Jayram, G, Johnson, S, Joshi, S, Liu, JJ, Lotan, Y, Marcq, G, Satkunasivam, R, Schuckman, A, Steinberg, G, Taylor, J, Linback, T, Pruthi, R, Cheung, A, Tosone, C, Kamat, AM, Palou, J. A Phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer-Trial in progress. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 External validation of Uromonitor® as a biomarker for optimization of NMIBC follow up by the CUETO group; evaluation-CUETO study

Briones, JR, Guerrero-Ramos, F, Mercade, A, Abadia, IB, Rodriguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Arrabal, M, Cardo, AL, Rodriguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Espilez, R, Valcárcel, IG, Zalabardo, DS, Esquinas, C, Mengual, L, Borque-Fernando, N, Esteban, LM, Palou, J, Witjes, JA, Pineiro, LM. External validation of Uromonitor® as a biomarker for optimization of NMIBC follow up by the CUETO group; evaluation-CUETO study. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Regulations on pregnancy and parenthood during urology residency in European countries

Afferi, L, Margue, G, Toribio-Vázquez, C, Baekelandt, L, Goujon, A, Ozalevli, M, Checcucci, E, Gugerli, A, Siech, C, Vásquez, JL, Melsert, BM, Mertens, LS, Liatsikos, E, Somani, BK, Galliol, A, Pradere, B, Breda, A, Whitburn, J, Rangel, E. Regulations on pregnancy and parenthood during urology residency in European countries. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Annual updates of the European Association of Urology (EAU) / European Society for Paediatric Urology (ESPU) Pediatric Urology Guidelines: Are large-language models better than the usual structured methodology?

Van Uitert, A, 't Hoen, LA, Bussmann, M, Bezuidenhout, C, Ribal, M, Canfield, SE, Yuan, Y, Omar, M, Castagnetti, M, Burgu, B, Kelly, F, Quaedackers, J, Rawashdeh, Y, Silay, S, Bujon, A, Bogaert, G, Pakkasjarvi, N, Skott, M, Kennedy, U, Gnech, M, Radmayr, C. Annual updates of the European Association of Urology (EAU) / European Society for Paediatric Urology (ESPU) Pediatric Urology Guidelines: Are large-language models better than the usual structured methodology?. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma

Afferi, L, Grossmann, NC, Gallioli, A, Cannoletta, D, Moschini, M, Soria, F, Juvet, T, Potretzke, A, Djaladat, H, Kikuchi, E, Mari, A, Khene, Z, Raman, J, Sfakianos, JP, Boormans, JL, Antonelli, A, Abdollah, F, Ploussard, G, Boorjian, SA, Shariat, SF, Heidenreich, A, Mattei, A, Breda, A, Pradere, B. Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 The dogma has been challenged: Local recurrence does not affect survival after glans-sparing surgery for penile cancer

Elst, L, Miletic, M, Roussel, E, Verdijk, R, Alnajjar, H, Di Nardo, N, Perri, D, Kaur, A, Sirard, RB, Basile, G, Bandini, M, Lobo, J, Hatzichristodoulou, G, Salonia, A, Breda, A, Spiess, PE, Parnham, A, Falcone, M, Bozzini, G, Muneer, A, Watkin, N, Ayres, B, Brouwer, OR, Albersen, M. The dogma has been challenged: Local recurrence does not affect survival after glans-sparing surgery for penile cancer. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Multicenter outcome analysis of different sheath sizes for Flexible And Navigable suction ureteric access Sheath (FANS) ureteroscopy. An EAU Endourology collaboration with the global FANS study group

Kwok, JL, Somani, B, Sarica, K, Yuen, SKK, Zawadzki, M, Castellani, D, Persaud, S, Chai, C, Kamal, W, Tefik, T, Tursunkulo, AN, Soebhali, B, El Hajj, B, Ko, R, Fong, KY, Dragos, L, Tanidir, Y, Angerri, O, Traxer, O, Gauhar,. Multicenter outcome analysis of different sheath sizes for Flexible And Navigable suction ureteric access Sheath (FANS) ureteroscopy. An EAU Endourology collaboration with the global FANS study group. EUROPEAN UROLOGY. 2025; 87DOI:. PMID:. IF:25.200(Q1/1D).

01/03/2025 Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS)

Fernández, CM, Sebio, A, Rincón, JO, Broto, JM, Benlloch, AM, Plaza, DM, Pousa, AL, Alegría, IG, Giuppi, M, Ballesteros, EC, Bernabeu, D, de Alava, E, Morales, CV. Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS). Clinical & Translational Oncology. 2025; 27(3)DOI:10.1007/s12094-024-03602-5. PMID:39158802. IF:2.500(Q3/6D).

01/03/2025 Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship

Fa-Binefa, M, Serra, J, Moya, E, Crusi, X, Gich-Saladich, I, Valera, M. Hydroxyapatite-coated total primary hip replacement: 28-year follow-up survivorship. Hip International. 2025; 35(2)DOI:10.1177/11207000241306004. PMID:39757970. IF:1.100(Q3/7D).

01/03/2025 Effectiveness of a nurse training intervention in the emergency department to improve the diagnosis and treatment of stemi patients: EDUCAMI study

Congost, GB, Brugaletta, S, Cerezo, PG, Bernal, JV, Comalat, MB, Mejías, SM, Millán, LM, Evangelista, SR, Gabalda, JR, Ortega, JT, Garcia-Picart, J, Jimenez-Kockar, M, Aizpurua, DA, Campmany, MP, Momblan, MAM. Effectiveness of a nurse training intervention in the emergency department to improve the diagnosis and treatment of stemi patients: EDUCAMI study. HEART & LUNG. 2025; 70DOI:10.1016/j.hrtlng.2025.01.006. PMID:39813828. IF:2.600(Q1/2D).

01/03/2025 Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

Moliner-Abós, C, Calvo-Barceló, M, Solé-Gonzalez, E, Martín, AB, Fluvià-Brugués, P, Sánchez-Vega, J, Vime-Jubany, J, Vallverdu, MF, Ferrer, MT, Tobias-Castillo, PE, Mancera, JCD, Vilardell-Rigau, P, Vila-Olives, R, Diez-López, C, Bayés-Genís, A, Aizpurua, DA, Ferreira-Gonzalez, I, Pérez, SM. Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study. EUROPEAN JOURNAL OF HEART FAILURE. 2025; 27(3)DOI:10.1002/ejhf.3463. PMID:39359034. IF:10.800(Q1/1D).

01/03/2025 ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS

Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

01/03/2025 USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY

Chico, A, Ampudia-Blasco, FJ, Daín, A, Scheibner, K, Dagenbach, N, Grifoll-Romero, L, Barmaymon, D, Vogt, G, Best, J, Etter, T. USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).

01/03/2025 Surpassing protein specificity in biomimetics of bacterial amyloids

Sanchez, JM, Voltà-Durán, E, Parladé, E, Mangues, R, Villaverde, A, Vázquez, E, Unzueta, U. Surpassing protein specificity in biomimetics of bacterial amyloids. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2025; 296DOI:10.1016/j.ijbiomac.2025.139635. PMID:39788253. IF:8.500(Q1/1D).

01/03/2025 Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach

Gil-Berrozpe, GJ, Segura, AG, Sánchez-Torres, AM, Amoretti, S, Giné-Servén, E, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldán, A, Forte, MF, Castro, J, Bergé, D, Rodríguez, N, Ballesteros, A, Mas, S, Cuesta, MJ, Bernardo, M. Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92DOI:10.1016/j.euroneuro.2024.12.002. PMID:39721378. IF:6.700(Q1/1D).

01/03/2025 Safety and Efficacy of Tranexamic Acid in General Surgery

Park, LJ, Marcucci, M, Ofori, SN, Borges, FK, Nenshi, R, Kanstrup, CTB, Rosen, M, Landoni, G, Lomivorotov, V, Painter, TW, Xavier, D, Martinez-Zapata, MJ, Szczeklik, W, Meyhoff, CS, Chan, MTV, Simunovic, M, Bogach, J, Serrano, PE, Balasubramanian, K, Cadeddu, M, Yang, I, Kim, WH, Devereaux, PJ. Safety and Efficacy of Tranexamic Acid in General Surgery. JAMA Surgery. 2025; 160(3)DOI:10.1001/jamasurg.2024.6048. PMID:39813061. IF:14.900(Q1/1D).

01/03/2025 Management of heart disease in renal transplant recipients: a national Delphi survey-based SET/SEC/SEN consensus document

García-Cosío, MD, Cruzado, JM, Farrero, M, Peiró, MTB, Crespo, M, Jiménez, JFD, Molina, BD, Rivera, CF, Bravo, IPG, Jiménez, VL, Melilli, E, Pérez, SM, Tamajón, MLP, Sousa, DR, Calabia, ER, Marrero, DH. Management of heart disease in renal transplant recipients: a national Delphi survey-based SET/SEC/SEN consensus document. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(3)DOI:10.1016/j.rec.2024.09.008. PMID:39442797. IF:4.900(Q1/2D).

01/03/2025 Identification of endoplasmic reticulum stress- associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm

Almendra-Pegueros, R, Rodriguez, C, Camacho, M, Sánchez-Infantes, D, Sánchez-Quesada, JL, Cáncer, S, Pérez-Marlasca, E, Medina-Gómez, G, Martinez-González, J, García-Redondo, AB, Galán, M. Identification of endoplasmic reticulum stress- associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm. CLINICAL SCIENCE. 2025; 139(6)DOI:10.1042/CS20242476. PMID:40072504. IF:7.700(Q1/2D).

01/03/2025 Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app

Cuixart, G, Corcoy, R, González, C. Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app. Hormones-International Journal of Endocrinology and Metabolism. 2025; 24(1)DOI:10.1007/s42000-024-00609-z. PMID:39412732. IF:2.500(Q3/7D).

01/03/2025 Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide

Beltrans, JS, Guinart-Cuadra, A, Piedras, A, Recios, SM, Mulet, M, Atenza, CZ, Alejandre, J, Joaquíns, AB, Sullivans, IG, Lópezs, JS, Vidal, S, Majems, M. Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

01/03/2025 Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence

Mañosa, M, Oller, B, Garcia-Planella, E, Guardiola, J, Cañete, F, González-Muñoza, C, Camps, B, Calafat, M, Doménech, E. Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. DIGESTIVE AND LIVER DISEASE. 2025; 57(3)DOI:10.1016/j.dld.2024.11.028. PMID:39730282. IF:3.800(Q2/3D).

01/03/2025 Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial

Dajti, E, Villanueva, C, Berzigotti, A, Brujats, A, Albillos, A, Genescà, J, García-Pagán, JC, Colecchia, A, Bosch, J. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial. JOURNAL OF HEPATOLOGY. 2025; 82(3)DOI:10.1016/j.jhep.2024.09.014. PMID:39303875. IF:33.000(Q1/1D).

01/03/2025 Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?

Añez, G, Torrente-Segarra, V, Bonet, M, Vilella, MC, Orpinell, L, Fernández, AP, Busquets-Pérez, N, Pascual-Pastor, M, Corominas, H, Diaz-Torne, C, Moya, P, De Agustin, JJ. Clinical and ultrasound optimization in rheumatoid arthritis for patients in sustained remission, can it work as a new optimization tool?. Journal Of Ultrasound. 2025; 28(1)DOI:10.1007/s40477-024-00963-z. PMID:39424691. IF:(Q/D).

01/03/2025 Baseline PD-L1 expression in circulating neutrophils predicts immune-related adverse events (irAEs) in patients with extensive-stage small-cell lung cancer from CANTABRICO trial

Piedra, A, Guinart-Cuadra, A, Recio, SM, Mulet, M, Atenza, CZ, Alejandre, J, Beltran, JS, Joaquín, AB, Sullivan, IG, López, JS, Casado, MDI, Aperribay, EA, Paz-Ares, L, Tain, PD, Vega, ALM, Callejo, A, Martos, JLL, Dominguez, M, Vidal, S, Majem, M. Baseline PD-L1 expression in circulating neutrophils predicts immune-related adverse events (irAEs) in patients with extensive-stage small-cell lung cancer from CANTABRICO trial. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

01/03/2025 TACTI-004: A double-blinded, randomized phase III trial in patients with advanced/metastatic non-small cell lung cancer receiving eftilagimod alfa (MHC class II agonist) in combination with pembrolizumab (P) and chemotherapy (C) versus placebo plus P plus C

Majem, M, O'Byrne, KJ, Lo Russo, G, Mueller, C, Triebel, F. TACTI-004: A double-blinded, randomized phase III trial in patients with advanced/metastatic non-small cell lung cancer receiving eftilagimod alfa (MHC class II agonist) in combination with pembrolizumab (P) and chemotherapy (C) versus placebo plus P plus C. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

01/03/2025 Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis

Gillessen, S, Tombal, B, Turco, F, Choudhury, A, Rodriguez-Vida, A, Gallardo, E, Velho, PI, Nolè, F, Cruz, F, Loriot, Y, McDermott, R, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Polo, MH, da Trindade, KM, Preto, DD, Skoneczna, I, Lecouvet, F, Coens, C, Fournier, B, Saad, F. Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis. EUROPEAN UROLOGY. 2025; 87(3)DOI:10.1016/j.eururo.2024.11.027. PMID:39827019. IF:25.200(Q1/1D).

01/03/2025 Patient-reported outcomes from CANTABRICO: Durvalumab plus platinum-etoposide in first-line treatment of extensive stage small cell lung cancer

Casado, MDI, Aperribay, EA, Campelo, MRG, Blanco, MCM, Tain, PD, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Majem, M, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Sureda, BM, Baret, M, Martos, JLL, Dominguez, M, Paz-Ares, L. Patient-reported outcomes from CANTABRICO: Durvalumab plus platinum-etoposide in first-line treatment of extensive stage small cell lung cancer. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

01/03/2025 First-line (1L) fulzerasib plus cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study

Majem, M, Gregorc, V, Lo Russo, G, Maio, M, Salvagni, S, Calderon, VG, Cao, MG, Contreras, SS, Koumarianou, A, Bearz, A, Caro, RB, Viteri, S, Sanmamed, MF, Zagouri, F, Bueno, MTM, Zhang, Y, Shan, Y, Zhu, H, Rosell, R. First-line (1L) fulzerasib plus cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

01/03/2025 Long-term survivors with extensive-stage small-cell lung cancer treated with first-line durvalumab plus carboplatin and etoposide: The CANTABRICO trial

Casado, MDI, Aperribay, EA, Campelo, MRG, Blanco, CM, Tain, PD, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Majem, M, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Sureda, BM, Baret, M, Martos, JLL, Dominguez, M, Paz-Ares, L. Long-term survivors with extensive-stage small-cell lung cancer treated with first-line durvalumab plus carboplatin and etoposide: The CANTABRICO trial. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).

01/03/2025 Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital

Rueda-Lara, A, Viñal, D, Martínez-Pérez, D, Alameda-Guijarro, M, Martin-Montalvo, G, Martínez-Recio, S, Peña-Lopez, J, Jiménez-Bou, D, Ruíz-Gutiérrez, I, García-Leal, A, Zwisler-Contreras, P, Ghanem, I, Custodio, AB, Pérez-Wert, P, Gutiérrez-Sainz, L, Palacios, ME, Feliu, J, Rodríguez-Salas, N. Analysis of tumor budding as a prognostic factor for recurrence in patients with stage II and III colon cancer. Experience in a tertiary hospital. ONCOLOGIST. 2025; 30(3)DOI:10.1093/oncolo/oyaf027. PMID:40152315. IF:4.200(Q2/3D).

01/03/2025 CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model

Szafranska, J, Batto, V, Alcaraz, J, Guinart-Cuadra, A, Brujats, A, Fajardo, J, Acin, V, Garcia, H, Casani, L, Villanueva, C, Ferré, M, del Olmo, TV, Tapias, EA. CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103704. PMID:. IF:4.200(Q1/1D).

01/03/2025 Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens

Kelley, J, Hissong, E, Szafranska, J, Qin, LH, Lamps, L, Jessurun, J. Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102849. PMID:. IF:4.200(Q1/1D).

01/03/2025 Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas

D'Angelo, E, Kingsley, L, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103197. PMID:. IF:4.200(Q1/1D).

01/03/2025 Methylation Profiling of Small Cell Carcinoma Hypercalcemic Type (SCCOHT) Identifies Three Groups with Distinct Clinical and Morphological Characteristics

Khubrani, R, Elyas, N, Hamidi, D, Stephan, L, Fotovati, R, Kommoss, F, Kommoss, F, Domecq, C, Hamel, N, Wang, YM, Huntsman, D, Zamarin, D, Boroujeni, AM, Chapel, D, Soslow, R, Mccluggage, G, Espinosa, I, Foulkes, W, Tessier-Cloutier, B. Methylation Profiling of Small Cell Carcinoma Hypercalcemic Type (SCCOHT) Identifies Three Groups with Distinct Clinical and Morphological Characteristics. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103244. PMID:. IF:4.200(Q1/1D).

01/03/2025 Histologic and Clinical Features of Esophageal Squamous Dysplasia: A Comparative Analysis of Basaloid, Classic, Differentiated, Spindle Cell, and Verrucous Variants

Hein, A, Szafranska, J, Jessurun, J, Panarell, N. Histologic and Clinical Features of Esophageal Squamous Dysplasia: A Comparative Analysis of Basaloid, Classic, Differentiated, Spindle Cell, and Verrucous Variants. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102833. PMID:. IF:4.200(Q1/1D).

01/03/2025 Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC

Escamilla-Gómez, V, Gutiérrez, VG, Alcalde-Mellado, P, Astibia-Mahillo, B, Chinea-Rodriguez, A, López-Corral, L, Acera-Gómez, M, Ochando, MKT, Borrego, AB, Pinedo, LG, Ripa, TZ, Vicent, MG, Benzaquén, A, García, II, Cantó, PA, Montoro, J, Martín-Domínguez, FM, Orti, G, Valcárcel, D, Benitez-Carabante, MI, Diaz-de-Heredia, C, Cañamero, E, Ferrá, C, García-Cadenas, I, Redondo, S, Sisinni, L, Perez-Martínez, A, Mussetti, A, Garcia-Mañó, L, Palomo-Moraleda, MD, González-Sierra, PA, Jurado, M, Perez-Simon, JA. Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC. BONE MARROW TRANSPLANTATION. 2025; 60(3)DOI:10.1038/s41409-024-02483-0. PMID:39663471. IF:5.200(Q1/1D).

01/03/2025 Breast radiotherapy planning: A decision-making framework using deep learning

Gallego, P, Ambroa, E, Pérezalija, J, Jornet, N, Anson, C, Tejedor, N, Vivancos, H, Ruiz, A, Barceló, M, Dominguez, A., Riu, V, Roda, J, Carrasco, P, Balocco, S, Díaz, O. Breast radiotherapy planning: A decision-making framework using deep learning. MEDICAL PHYSICS. 2025; 52(3)DOI:10.1002/mp.17527. PMID:39625151. IF:3.200(Q1/3D).

01/03/2025 Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.

Santos García D, Pagonabarraga Mora J, Escamilla Sevilla F, García Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, Linazasoro Cristóbal G, Luquín Piudo MR, Martínez Castrillo JC, Jesús Maestre S, Vela Desojo L, Campos Lucas FJ, Caballero Martínez F, Mir P. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.. Neurologia. 2025; 40(2)DOI:10.1016/j.nrleng.2023.04.008. PMID:37419211. IF:(Q/D).

01/03/2025 Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results

Sumarroca, A, Vega, C, López, S, Leidinger, A, Pedemonte, G, León, X, Costa-González, JM. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results. Acta Otorrinolaringologica Espanola. 2025; 76(2)DOI:10.1016/j.otorri.2024.10.001. PMID:39923991. IF:(Q/D).

01/03/2025 Depressive Symptoms and Amyloid Pathology

Wiels, WA, Oomens, JE, Engelborghs, S, Baeken, C, von Arnim, CAF, Boada, M, Didic, M, Dubois, B, Fladby, T, van der Flier, WM, Frisoni, GB, Froehlich, L, Gill, KD, Grimmer, T, Hildebrandt, H, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Lee, DY, Lleo, A, Martinez-Lage, P, de Mendonca, A, Meyer, PT, Kapaki, EN, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sanchez-Juan, P, Santana, I, Sarazin, M, Scarmeas, N, Skoog, I, Snyder, PJ, Sperling, RA, Villeneuve, S, Wallin, A, Wiltfang, J, Zetterberg, H, Ossenkoppele, R, Verhey, FRJ, Vos, SJB, Visser, PJ, Jansen, WJ. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025; 82(3)DOI:10.1001/jamapsychiatry.2024.4305. PMID:39841452. IF:17.100(Q1/1D).

01/03/2025 Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica

Fraga Rodríguez GM, Devolder Nicolau, A. Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica. Anales de Nefrología Pediátrica. 2025; 1(10)DOI:. PMID:. IF:(Q/D).

01/03/2025 Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.

Majoie M, Visser A, Ulubas M, van Mastrigt G, Alonso-Coello P, Valli C, Niño de Guzman E, Gartlehner G, Nussbaumer-Streit B, Klerings I, James R, Service D, Evers S, Kleijnen J, Leone M, Verstegen D. Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.. Neurology. Education. 2025; 4(1)DOI:10.1212/NE9.0000000000200198. PMID:40041757. IF:(Q/D).

01/03/2025 Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus

Villaverde, S, Pedrero-Tomé, R, Papaevangelou, V, Syridou, G, Karagiannidou, S, Lyall, H, Payne, H, Frick, MA, Soler-Palacín, P, Baquero-Artigao, F, Rodríguez-Molino, P, Fortuny-Guasch, C, Rios-Barnés, M, Sánchez-Mateos, M, Saavedra-Lozano, J, Bringué, X, Moliner, E, Castells, L, Muga, O, Vives-Oños, I, Gkentzi, D, Lombardi, G, Tagarro, A, Colino, E, Couceiro, JA, Rojo, P, de Vergas, J, Blázquez-Gamero, D. Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2025; 44(3)DOI:10.1097/INF.0000000000004583. PMID:39383383. IF:2.200(Q2/3D).